Background: Atopic Dermatitis (AD) is an allergic inflammatory skin disease with significant cost and morbidity to the patients and their families. Vitamin D has been suggested to have a role in the pathogenesis of allergic disorders, including AD. Objective: The aim of the study was to measure the serum levels of vitamin D in the form of 25-hydroxy vitamin D in children with AD and to correlate them with the severity of the disease. Patients and methods: The study included forty children with the clinical diagnosis of AD. Using Scoring Atopic Dermatitis (SCORAD) index, the patients were divided into three groups; mild (SCORAD index<25), moderate (25-50) and severe (>50). Vitamin D levels were measured in the sera of the patients using Chemiluminescent method. Specific IgE to Staphylococcus aureus (S.aureus) Enterotoxins (A, B and C) and Malessazia furfur (M.furfur) in the sera of the patients was also measured using Immunocap system. Results: AD was mild in 16 patients, moderate in 14 patients and severe in 10 patients. The mean SCORAD index ±SD was 14.01±5.6, 38.71±7.8 and 60.8±7.5 in the three groups respectively. Mean vitamin D levels ±SD in the sera of the patients in ng ml -1 were sufficient (36.3±13.06) in 15 patients, insufficient (26.6±7.4) in 16 patients and deficient (19.8±5.2) in 9 patients. There was a significant inverse correlation between the serum levels of vitamin D and the severity of AD (r=-0.48, P=0.003). There was also a significant difference between the mean serum level of vitamin D in mild and moderate AD (P<0.05), and mild and severe AD (P<0.05). Specific IgE to S.aureus enterotoxin and to M.furfur antigens was more in patients with severe AD who had deficient levels of vitamin D than in those with mild or moderate disease. Conclusion: Vitamin D level is inversely related to the severity of the disease in AD patients and consequently it may have a role in its treatment.
INTRODUCTION
topic dermatitis (AD) is an allergic chronic inflammatory type of eczema. It is an important skin condition with significant cost and morbidity to the patients and their families. The underlying cause of AD has not been established, however several studies have shown initial epidermal barrier defect with subsequent immune activation as the underlying mechanism of the disease 
Vitamin D insufficiency data is expanding to include evidence of its role in asthma, allergic disorders and AD (2) . In addition to its well documented relationship with rickets and bone metabolism, vitamin D is now recognized as immunomodulator (2) . However, conflicting data exist with respect to the role of vitamin D in the pathogenesis of allergic disorders . The prevalence of AD and allergic rhinitis was higher in subjects who received vitamin D supplements in infancy . In another prospective study of 4000 infants, in whom 98% were supplemented with vitamin A and D (400 I U/day of vitamin D), in either a water soluble or peanut oil form, showed that infants who received water soluble supplements had a greater risk of asthma, food sensitivity and aeroallergen sensitization at the age of 4 years than infants given peanut oil form . On the other hand, it has been shown that infants born to mothers with low vitamin D intake (6) or low fish consumption (7) during pregnancy presented an increased prevalence of atopic manifestations in their babies. A greater risk of AD has been observed in infants born in autumn and winter as compared to those born in spring and summer (8) . In 2012, Amestejani et al. reported beneficial effects on AD from oral supplementation with vitamin D in a small sample size of children with winter related worsening of AD (9) . Vitamin D has been demonstrated to have an effect on the integrity of the permeability barrier of the epidermis, together with its role in maturation and activity of lymphoid tissues involved in the development and control of allergic manifestations Only children who were not taking vitamin D supplements for at least 6 months and those who had not received topical steroids in the previous 4 weeks were included in this study. Patients who received calcineurin inhibitors (in the last 2 weeks) or any systemic anti-inflammatory treatments (in the previous last month) were also excluded from the study. An informed consent was taken from the parents according to the local Hospital's Ethics. Methods: All the patients were subjected to complete medical history, general medical and dermatological examinations; AD was diagnosed according to the U.K. Working Party's diagnostic criteria for AD. 111 (10) . The severity of the disease was evaluated using SCORAD index as mild <25, moderated 25-50 and severe >50 as defined in previous studies (11) . A blood sample was taken from every patient and the serum was separated. Vitamin D levels in the serum were measured once using chemiluminescent method (LIAISon 25-OH vitamin D Total; Driason, Saluggia, Italy). Values were used as a continuous variable and vitamin D amounts were also categorized, in a descriptive analysis as follows: sufficient (30-40ng mL -1 ), insufficient (20-30 ng mL -1
) and deficient (< 20 ng mL -1 )
. Specific IgE (SIgE) to S.aureus Enterotoxin (SE) A, SEB and SEC and SIgE to M.furfur were assayed by Immuno Cap system (phadia, Milan, Italy)). Specific IgE concentration 0.35 Ku L -1 ) were considered to be positive (13) .
Statistical methods:
Comparison of vitamin D levels among AD patients with different SCORAD index was performed by ANOVA, p<0.05 was considered significant. The association between SCORAD index and vitamin D value was performed using a Pearson's correlation test. Results: This study conducted on forty AD children. Their ages ranged from 1-12 years. They were 18 girls and 22 boys. The mean SCORAD value±SD were 14.o1±5.6, 38.71±7.8 and 60.8±7.5 in mild (<25), moderate (25-50) and severe (>50) AD respectively, as shown in table (1). figure (1) .
The highest serum levels of 25 hydroxy vitamin D were found in AD patients with mild SCORAD. There was a significant statistical difference between the mean serum vitamin D levels in mild and severe AD patients (P value < 0.05). The statistical difference in the serum levels of hydroxyl vitamin D in patients with mild and moderate AD was also significant (P<0.05), as shown in Figure ( MF: M.furfur. DISCUSSION Dysfunctions of both epidermal barrier and immune system represent the main pathogenic mechanisms of atopic dermatitis and patients with this disease can have defects in both permeability and antimicrobial barriers of the stratum corneum (SC) (14) . The permeability barrier consists of hydrophobic lipids that percolate the environment surrounding SC and prevent water loss into the extracellular environment (14) . Overactivity of the enzymes, serine proteases, secondary to genetic defects such as defects of the gene encoding filaggrin, and environmental stimuli like alkaline soaps promotes reduction of hydration and extracellular lipids in SC, introduction of antigens and promotion of inflammation (14) . Loss of function mutation in the gene encoding filaggrin are associated with AD (15) . The barrier dysfunction also involved antimicrobial barrier. Antimicrobial peptides (AMPS) represent an important part in this barrier, as a first line defense against infection. cathelicidin is one of the most important AMPs and is expressed in keratinocytes and mast cells (16) . Its deficiency is known to be associated with AD (17) as it plays a role in immune system signaling that enhances antimicrobial activity against S.aureus and M.furfur.
Vitamin D data expanded to involve its roles in the pathogenesis of allergic disorders including AD , so we studied in this work the relation between Vitamin D serum levels and atopic manifestations in AD of children. We found an inverse relation between the serum levels of vitamin D in children with AD and the severity of the disease as evaluated by SCORAD . In contrary, Back et al have shown a direct correlation between vitamin D levels and severity of the disease in AD patients
(5)
. We can explain our results by the fact that the enzymes responsible for the conversion of vitamin D into the active form of the vitamin are found in the keratinocytes (18) . Vitamin D has a role in the permeability barrier in the epidermis. Its beneficial effect on the permeability barrier was evidenced by the presence of the lower levels of multiple proteins in the null mice compared to the wild type controls. These proteins (including filaggrin) are necessary for formation of the SC (19) . In the same study, Bikle and his colleagues measured the expression of 25-hydroxyvitamin D-1α-hydroxylase in the null mice (this enzyme is essential for the initial hydroxylation of vitamin D to 25 hydroxyvitamin D), following tape disruption, null mice has significantly delayed barrier recovery (19) Vitamin D in addition plays a role in the antimicrobial barrier of the skin as it has a role in the immune system signaling. It has been shown to have a significant role in cathelicidin expression in the skin (16) , that enhances antimicrobial activity against S. aureus and M.furfur. Wang and his group demonstrated that promoters of cathelicidin and beta-2 defensin (AMP) genes consensus vitamin D response element and that 1,25 dihydroxy vitamin D promotes antimicrobial gene expression (20) . It has been proposed that skin infection and injury leads to activation of CYP27B1 (the enzyme responsible for the conversion of vitamin D into the active form) and up-regulated VDR (vitamin D receptors) expression which in turn leads to increased production of activated vitamin D and AMPS (21) Vitamin D decreases synthesis of IL-1, IL-6 and RANTES (regulated and normal T cell expressed and secreted) that decreases inflammation of the epidermal keratinocytes (22) . VDRs are located on macrophages and dendretic cells (DCS) as is CYP27B1. 1, 25 dihydroxy vitamin D has been shown to have inhibitory effects on the differentiation of DCS (23) . In vitro treatment of DCS with vitamin D leads to decrease in IL-12 and enhanced IL-10. These cytokines effects along with the inhibitory effects on DCS maturation promote tolerogenic properties and suppressor T cells induction (22) . Vitamin D induced tolerogenic DCS and increased T regulatory cells in mice (24) . In this study, an increased prevalence of patients who were positive for the presence of Specific IgE either to S.aureus or M.furfur or both was found in patients with severe AD (40%,50%,50%and70% of patients were positive to presence of SIgE to SEA,B,Cand M.furfur respectively) than those in patients with mild (31%,31%,37.5%and31%) and moderate (35.7%,28.5%,35.7%and42%) AD. Serum vitamin D was also at its lowest levels in patients with severe AD (19.8±5.2 ng ml -1 ). This can be explained by the decreased expression of AMPS that represent an important part in the antimicrobial barrier of the skin against bacteria and fungi in patients with low vitamin D levels (16, 21) .
CONCLUSION AND RECOMMENDATION:
Vitamin D serum level is inversely correlated with the disease severity in children with AD. This indicates that Vitamin D may have a role in the pathogenesis of AD and consequently a beneficial effect in the treatment and prevention of the disease, which needs further research. 
